Free Virtual Consultations. Corona Virus Related Cases Click Here.

1 Killed in Crash on Interstate 15 Near Glen Helen Parkway

Pedestrian Hit by Car in Fatal San Bernardino Accident

San Bernardino, CA (March 30, 2020) – A pedestrian was killed in a crash in San Bernardino. The fatal accident occurred on the evening of March 30 on Interstate 15.

Emergency crews received reports of a body on southbound Interstate 15, near Glen Helen Parkway. A man was found dead at the accident scene. Witnesses saw two pedestrians running across the freeway.

The driver of a Honda Civic reported hitting debris in the roadway. He remained at the accident scene. Several other vehicles had stopped in the center divider. One vehicle was in a ditch.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#San Bernardino 


March 10, 2020

Man Killed in Crash at Union Avenue and 2nd Street

Victim Hit by Truck in Fatal Bakersfield Accident ...

November 7, 2019

7 Injured in Crash at Pitta and Market Streets

Police Chase Leads to San Diego Accident...

November 27, 2019

1 Injured in Crash at Manning and McCall Avenues

2 Vehicles Collide in Selma Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.